Biotech Stock Tip: Make the Most of the “Novel” Drug Rush
In this episode of The Bull & The Bear, we examine how novel drug approvals can impact biotech stocks like Biogen Inc. (Nasdaq: BIIB).
Read More
Author: Matthew Clark
Kroger Earnings + More Bad News on the Inflation Front?
Money & Markets Week Ahead for June 13, 2021: Earnings season continues to slow down as companies prepare for the next round of quarterly reports. I look at an Israeli “software as a service” IPO and analyze the earnings of a popular grocery store.
Best Cannabis ETF? (YOLO, MJ or MSOS)
In this week’s Marijuana Market Update, I tell you which cannabis ETF out of three tickers (MSOS, YOLO and MJ) is the best buy right now.
Don’t Count on Biogen Stock Gains — Alzheimer’s Drug Has Baggage
In this episode of The Bull & The Bear, I tell you if Biogen stock (Nasdaq: BIIB) is a buy after its recent Alzheimer’s drug breakthrough.
GameStop Earnings Preview: This Meme Stock Has a Lot to Prove
Money & Markets Week Ahead for June 6, 2021: GameStop’s earnings should tell us if this “meme” stock’s recent surge is warranted.
Watchlist
